HOME SCHEDULE REGISTRATION
SPONSORS
(JQH) (SQN) ePOSTERS SQN FRANÇAIS
Powered by liV Agency

For all enquiries:

Marie Goubran
marie.goubran@livagency.ca
(514) 220-2743
Saturday, November 28, 2020
9am to Noon

Friday, November 27, 2020
1pm to 4pm

Sunday, November 29, 2020
9am to Noon

REGISTER
Powered by liV Agency

For all enquiries:

Marie Goubran
marie.goubran@livagency.ca
514-220-2743
9:00 am - 9:05 am
Dr. Michel Vallée, president of the JQH
Welcoming Remarks
9:05 am - 9:50 am
Dr. Mélanie Godin / Éléonor Riesco, PhD.
Physical Rehabilitation in Hemodialysis [French presentation]
  • Recognize the benefits of physical activity for hemodialysis patients
  • Initiate a physical rehabilitation program in a hemodialysis setting
  • Evaluate the progress of hemodialysis patients in a physical exercise program
9:50 am - 10:35 am
Dr. Martine Raymond
Medical Aid in Dying in Hemodialysis [French presentation]
  • Review the definition of medical aid in dying and the legal framework surrounding medical assistance in dying in Quebec
  • Identify the specific criteria a patient must meet to be eligible for medical assistance in dying
  • Outline the medical aid in dying procedures for both patients and physicians.
10:35 am - 10:45 amHealth Break
10:45 am - 11:30 am
Marisa Battistella, pharm.
Conférence Pierre-Nantel: Less Is More!
Polypharmacy and Deprescribing in Patients with End Stage Kidney Disease
  • Identify the most common medications used in ESKD patients
  • Discuss potential medications that are inappropriately used in ESKD patients
  • Evaluate specific deprescribing opportunities for ESKD patients
11:30 am - 11:55 am
Dr. Rita Suri
The Impact of Covid-19 in Hemodialysis Units in Quebec: An Update from the Quebec Renal Network
  • Describe the impact of COVID-19 in hemodialysis units in Quebec on infection control practices, workflow, and non-dialysis care
  • Review the short- and long-term consequences of COVID-19 in hemodialysis patients in Quebec and elsewhere
  • Discuss how the Quebec Renal Network can grow to facilitate clinical trials and prospective studies in hemodialysis units in the future
11:55 am - noon
Dr. Michel Vallée
Closing Remarks